Allocations
Partnerize, a provider of partner marketing software for global brands, has secured USD9 million (GBP6.91 million) in additional investment, at a USD127 million (GBP97.46 million) valuation.
The round was led by GP Bullhound, a leading global technology advisory and investment firm.
The proceeds will be used for additional sales and marketing expansion and support further growth and development of a global partner ecosystem centred on the company’s SaaS partner management platform, with a small portion to be used for secondary purposes.
Newcastle on Tyne-based Partnerize joins existing GP Bullhound portfolio companies, including Slack, Spotify, Unity, and Tradeshift,
Gridiron Capital has made an investment in Royal Paper, a private label consumer-packaged goods company providing a broad range of tissue products to blue chip customers both in the At-Home and Away-from-Home markets.
Headquartered in Phoenix, AZ, Royal Paper offers a complete selection of high-quality tissue products including bath tissue, paper towels, napkins, and facial tissue comprised of both premium virgin pulp-based products, which rival national brands, and environmentally friendly recycled tissue products. Royal Paper has a strong track record of growth driven by a core philosophy of focusing on customer service and consistently supplying high-quality products at a leading
Private equity firm Avista Capital Partners (Avista) is to acquire G&W Laboratories’ extended topicals and dermatology business unit (G&W Dermatology).
The transaction does not involve G&W Labs’ other businesses, including investments to drive efficiency in the pharmaceutical value chain and contract manufacturing operations in Sellersville, PA and Lincolnton, NC.
G&W Dermatology has a market-leading and diversified portfolio of approximately 35 self-labelled generic topical dermatology products that are currently marketed and sold in the US. In addition, the Company maintains partnership arrangements on a number of products and is a contract manufacturer for select products owned by other pharmaceutical companies.
Independent investment manager Albion Capital is intending to raise up to GBP36 million through a launch in early January 2019 of its top up offers for its six venture capital trusts (Albion VCTs).
The fundraising is expected to target GBP6 million for each of the six Albion VCTs: Albion Venture Capital Trust PLC, Albion Development VCT PLC, Albion Enterprise VCT PLC, Albion Technology & General VCT PLC, Crown Place VCT PLC and Kings Arms Yard VCT PLC.
The Albion VCTs’ combined portfolios have a value of approximately GBP400 million, diversified across approximately 60 businesses. The planned top up offers
OMERS Private Equity, the private equity arm of OMERS, is to to sell MatrixCare Holdings (MatrixCare) to ResMed Operations (ResMed) for USD750 million.
Based in Minneapolis, Minnesota, MatrixCare is an industry leading, SaaS-based, long-term post-acute care (LTPAC) technology provider used in more than 13,000 facility-based care settings and 2,500 home care, home health and hospice organisations.
“We first acquired MatrixCare as part of a larger acquisition in 2010. Since bringing John Damgaard in as CEO in 2012, OMERS has worked with John and the Company to enhance its ability to serve customers across the LTPAC continuum,” says Mark Van Wart, Managing
Noerr has advised the Danish parent cooperative of the Arla Foods Group, Arla Foods amba, on the cross-border merger of its German members MUH Arla eG and Hansa Arla Milch eG by the formation of a Danish European Cooperative Society (SCE), namely Arla Foods 2018 SCE.
Other participating cooperatives in the merger were the Group’s British member The UK Arla Farmers’ Cooperative Limited as well as its two Belgian members Büllinger–Sankt Vither Molkereigenossenschaft and EUREGIO Arla Genossenschaftsmolkerei. The merger was registered with the Danish Business Authority on 1 October 2018.
The merger of Arla Food’s central European and British local
Springrowth SGR, a wholly-owned subsidiary of Muzinich & Co Ltd, has held the first close of the Diversified Enterprises Credit Fund (DECF), the first parallel lending vehicle to be launched in Italy.
The DECF, which is a closed-ended vehicle with an eight-year investment term, has received EUR210 million in commitments from a broad group of Italian and international institutional investors. The European Investment Fund (EIF) and the Cassa Depositi e Prestiti (CDP) acted as anchor investors in this initiative to bring capital market funding to Italian SMEs in parallel with the banking sector.
Gianluca Oricchio, Springrowth CEO, says: “Through this strategy we will engage as a primary participant in middle-market bank loans, acting as a parallel lender alongside Italian banks, to enable the
InMotion Ventures, Jaguar Land Rover’s venture capital fund, today announces its investment in Arc, the company behind Vector – the world’s first fully-electric motorcycle with a Human Machine Interface (HMI).
The investment from InMotion Ventures, along with Mercia Fund Managers, the Proof of Concept & Early Stage Fund which is part of the Midlands Engine Investment Fund, and a number of industry specialist angels, will support Arc with its global ambition for Vector to be the cleanest, safest, and most fulfilling motorcycle on the road.
The brand new bike will be revealed today at the Milan Motorcycle. The Arc
Hyundai CRADLE, Hyundai Motor Company’s corporate venturing and open innovation business, has made a strategic investment in allegro.ai, a technology company specialising in deep learning (DL) – based computer vision.
Founded in 2016, allegro.ai offers the first end-to-end DL lifecycle management solution focused on deep learning as it applies to computer vision. The company’s platform simplifies the process of developing and managing deep learning-powered solutions – such as autonomous vehicles, drones, security, logistics and others.
“Deep learning computer vision is one of the core technologies that can be applied to autonomous driving to navigate roads and make quick decisions in real-time – and
Foresight Group (Foresight) has invested GBP2.5 million to support the growth of North Wales-based software provider Cimteq Limited.
This is the thirteenth investment by the GBP58 million Foresight Regional Investment Fund (FRIF), focussed on North Wales and the North West of England. Since December 2015 the Fund, backed by local institutional investors including the Clwyd Pension Fund, has supported the creation of 260 new jobs across the investment area. Cimteq marks the Fund’s first investment into the thriving North Wales SME community, supporting growth in the region.
Located in Wrexham, Cimteq specialises in the development, supply and support of
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
